BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15590260)

  • 1. Anesthetic management for cardioverter-defibrillator implantation in a patient with Kearns-Sayre syndrome.
    Hara K; Sata T; Shigematsu A
    J Clin Anesth; 2004 Nov; 16(7):539-41. PubMed ID: 15590260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes in a patient with Kearns-Sayre syndrome: a fortunate finding.
    Subbiah RN; Kuchar D; Baron D
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):137-9. PubMed ID: 17241330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anesthesia in Kearns-Sayre syndrome (mitochondrial myopathy)].
    Sabaté S; Ferrándiz M; Paniagua P; Villamor JM; Vilanova F; Villar-Landeira JM
    Rev Esp Anestesiol Reanim; 1996; 43(7):255-7. PubMed ID: 8966354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [General anesthesia in two patients with mitochondrial myopathy].
    Klockgether-Radke A; Henze T; Braun U; Kettler D
    Anaesthesist; 1993 Feb; 42(2):111-4. PubMed ID: 8470783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anesthetic management for implantation of implantable cardioverter-defibrillators].
    Hara M; Uchida O; Kuro M; Kurita T
    Masui; 1999 Jul; 48(7):747-52. PubMed ID: 10434515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placement of an implantable cardioverter-defibrillator in an infant with congenital long QT syndrome: anesthetic considerations.
    Kansara B; Singh A; Kaushal S; Saxena A
    Ann Card Anaesth; 2011; 14(2):122-6. PubMed ID: 21636934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes in Kearns-Sayre syndrome.
    Wilmin S; De Bels D; Knecht S; Gottignies P; Gazagnes MD; Devriendt J
    Pract Neurol; 2012 Jun; 12(3):199-201. PubMed ID: 22661355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles.
    Imamura T; Sumitomo N; Muraji S; Mori H; Osada Y; Oyanagi T; Kojima T; Yoshiba S; Kobayashi T; Ono K
    Int J Cardiol; 2019 Mar; 279():105-111. PubMed ID: 30642644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of propofol combined with nitrous oxide and fentanyl in anesthetic management of a patient with mitochondrial encephalomyopathy].
    Shibukawa K; Kawamata M; Seki S; Narimatsu E; Namiki A
    Masui; 2002 Aug; 51(8):888-91. PubMed ID: 12229139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Propofol anesthesia for a patient with Arnold-Chiari deformity].
    Nakayama Y; Sonoda H; Namiki A
    Masui; 1998 Jun; 47(6):726-9. PubMed ID: 9691593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kearns-Sayre syndrome: a case report and review of cardiovascular complications.
    Young TJ; Shah AK; Lee MH; Hayes DL
    Pacing Clin Electrophysiol; 2005 May; 28(5):454-7. PubMed ID: 15869681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kearns-Sayre syndrome. A rare indication for prophylactic cardiac pacing].
    Lewy P; Leroy G; Haiat R; Halphen C; Kerrad L; Sander M; Weingrod M
    Arch Mal Coeur Vaiss; 1997 Jan; 90(1):93-7. PubMed ID: 9137719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of Kearns-Sayre syndrome].
    Kokot W; Iwaszkiewicz-Bilikiewiczowa B; Lewczuk A; Sworczak K
    Klin Oczna; 1996; 98(4):327-30. PubMed ID: 9463130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anesthetic management for AICD (automatic implantable cardioverter defibrillator) implant surgery].
    Ohnishi Y; Kikumoto K; Hayami H; Kuro M
    Masui; 1996 Feb; 45(2):239-43. PubMed ID: 8865716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anesthetic management of cardiac tamponade after dual-chamber implantable cardioverter defibrillator implantation in a patient with dilated cardiomyopathy.
    Sato Y; Horiguchi T; Nishikawa T
    J Clin Anesth; 2004 Nov; 16(7):554-6. PubMed ID: 15590264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nitrous oxide on propofol requirement during target-controlled infusion for oocyte retrieval.
    Handa-Tsutsui F; Kodaka M
    Int J Obstet Anesth; 2007 Jan; 16(1):13-6. PubMed ID: 17125991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthetic management of Kearns-Sayre syndrome. Case report.
    Talaván Serna J; Belmonte Bayo L; Gutiérrez Rueda E; Rodríguez Martínez S
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Apr; 68(4):232-234. PubMed ID: 33160688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial cytochrome b gene deletion in Kearns-Sayre syndrome associated with a subclinical type of peripheral neuropathy.
    Zanssen S; Molnar M; Buse G; Schröder JM
    Clin Neuropathol; 1998; 17(6):291-6. PubMed ID: 9832255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kearns-Sayre syndrome associated with trifascicular block and QT prolongation.
    Karanikis P; Korantzopoulos P; Kountouris E; Dimitroula V; Patsouras D; Pappa E; Siogas K
    Int J Cardiol; 2005 May; 101(1):147-50. PubMed ID: 15860400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anesthetic management for cardioverter defibrillator implantation in a patient with preoperatively undiagnosed myotonic dystrophy].
    Asada M; Suzuki H; Sumitomo M
    Masui; 2001 Oct; 50(10):1136-8. PubMed ID: 11712353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.